You are here: Industry Insights > COVID-19

News List

Leading BioSciences Drug May Help Critical COVID-19 Patients contractpharma
April 09, 2020
Investigational drug, LB1148, being considered to treat respiratory distress and organ dysfunction in critically ill COVID-19 patients.
Vertex Foundation donates funds to support COVID-19 efforts pharmatimes
April 08, 2020
As of this morning – Wednesday April 8 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 55,242 with 6,159 deaths.
Oxford Biomedica joins consortium for promising COVID-19 vaccine pharmatimes
April 08, 2020
As of this morning – Wednesday April 8 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 55,242 with 6,159 deaths
Johnson & Johnson announces a lead vaccine candidate for COVID-19 worldpharmanews
April 08, 2020
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program worldpharmanews
April 08, 2020
Novartis announced plans to initiate a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi® (ruxolitinib) for treatment of a type of severe immune overreaction ...
BD, BioGX Announce FDA Emergency Use Authorization for COVID-19 Diagnostic Test americanpharmaceuticalreview
April 08, 2020
BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen ...
Vanda Initiates Study of Tradipitant in Hospitalized Patients with Severe COVID-19 Pneumonia americanpharmaceuticalreview
April 08, 2020
Vanda Pharmaceuticals announced the initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19.
Trxade Group Files FDA Emergency Use Authorization for Rapid COVID-19 Testing Kit americanpharmaceuticalreview
April 08, 2020
Trxade Group has filed for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) in collaboration with its partnered manufacturer of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit.
Montefiore, Einstein Begin Coronavirus Treatment Trial americanpharmaceuticalreview
April 08, 2020
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.
COVID-19 convalescent plasma therapy shows promise in pilot study europeanpharmaceuticalreview
April 08, 2020
A pilot trial of convalescent plasma therapy in 10 severe COVID-19 patients has shown it may be a safe and promising therapeutic option.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page